Mckesson Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
McKesson Corporation (MCK)
McKesson Corporation stock price live, this page displays NYSE MCK stock exchange data. View the MCK premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the McKesson Corporation real time stock price chart below.
What Is the McKesson Corporation Stock Price Today?
The McKesson Corporation stock price today is 761.89.
What Is the Stock Symbol for McKesson Corporation?
The stock symbol for McKesson Corporation is "MCK."
What Stock Exchange Does McKesson Corporation Trade On?
McKesson Corporation is listed and trades on the NYSE stock exchange.
Is McKesson Corporation a Good Stock to Buy?
Determining whether McKesson Corporation, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MCK quote. (ISIN: US58155Q1031) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
What Is the McKesson Corporation Stock Price Today?
The McKesson Corporation stock price today is 761.89.
What Is the Stock Symbol for McKesson Corporation?
The stock symbol for McKesson Corporation is "MCK."
What Stock Exchange Does McKesson Corporation Trade On?
McKesson Corporation is listed and trades on the NYSE stock exchange.
Is McKesson Corporation a Good Stock to Buy?
Determining whether McKesson Corporation, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MCK quote. (ISIN: US58155Q1031) Test %CURRENT_YEAR% | %DIVIDEND_YIELD% | %UPSIDE_OR_DOWNSIDE%
Fair Value
An estimate of a McKesson's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
761.89
782.48
52 wk Range
637.00
999.00
MCK is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a McKesson's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
761.89782.48
52 wk Range
637.00999.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.42%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.42%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
MCK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a McKesson's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
949.73
Upside
+24.65%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 18 consecutive years
- Mckesson Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Mckesson Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Mckesson Corp receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
15 Buy
2 Hold
0 Sell
Ratings:
17 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 949.73
(+24.65% Upside)
McKesson Corporation SWOT Analysis
Oncology Powerhouse | McKesson's strategic focus on oncology and biopharma services positions it for sustainable double-digit growth in high-value healthcare segments |
Acquisition Spree | Explore McKesson's bold moves in acquiring oncology assets, including a $2.49 billion stake in Florida Cancer Specialists, enhancing market position |
Financial Resilience | Learn how McKesson's strong US Pharma segment performance and raised guidance reflect its robust financial health and growth potential |
Data-Driven Future | Delve into McKesson's enhanced data capabilities from recent acquisitions, potentially unlocking new revenue streams and competitive advantages |
McKesson Corporation Earnings Call Summary for Q4/2026
- McKesson Q4 FY2026 EPS of $11.69 beat estimates by 1.04%, up 16% YoY; revenue of $92.3B missed forecast by 8.82%, totaling $403B for full year.
- Stock rose 0.85% to $750.01 in aftermarket trading despite revenue shortfall; full-year adjusted operating profit increased 15% to $6.5B.
- Company projects FY2027 EPS between $39.52-$43.38, driven by Oncology and Multispecialty segment growth and biopharma services innovation.
- CFO Britt Vitalone retiring; emphasized strategic initiatives and operational excellence while maintaining aggressive share buybacks and 18-year dividend streak.
- Key risks include supply chain disruptions, market saturation, inflation pressures, and regulatory changes from Inflation Reduction Act.
Last Updated: 08/05/2026, 03:16
Read Full TranscriptEarnings
Latest Release
May 07, 2026
EPS / Forecast
11.69 / 11.57
Revenue / Forecast
92.3B / 101.23B
Compare MCK to Peers and Sector
Metrics to compare | MCK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMCKPeersSector | |
|---|---|---|---|---|
P/E Ratio | 19.2x | 22.0x | −0.5x | |
PEG Ratio | 0.39 | 0.24 | 0.00 | |
Price/Book | −42.2x | 1.3x | 2.6x | |
Price / LTM Sales | 0.2x | 0.6x | 3.1x | |
Upside (Analyst Target) | 24.0% | 28.8% | 55.1% | |
Fair Value Upside | Unlock | −4.1% | 7.2% | Unlock |
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies; gene therapy with InspiroGene, practice consulting, and vaccine distribution services; and technology solutions, as well as research, insights, technologies, and services to improve cancer and specialty care. In addition, the company helps in solving medication access, affordability, and adherence challenges for patients by working across healthcare to connect patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies. Further, it offers technology services, which includes electronic prior authorization, prescription price transparency, benefit insight, dispensing support services, patient enrollment, third-party logistics, and wholesale distribution support; medical-surgical supplies, laboratory equipment, pharmaceutical distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, and hospital reference labs, nursing homes, hospice and home health care agencies, government facilities ,and online marketplaces and retailers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the McKesson (MCK) Stock Price Today?
The McKesson stock price today is 761.89 USD.
What Stock Exchange Does McKesson Trade On?
McKesson is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for McKesson?
The stock symbol for McKesson is "MCK."
What Is the McKesson (MCK) Afterhours Price Today? (Afterhours variable test: 761.80) Current Date: May 20, 2026
After hours price: 761.80. After hours price change (units): -0.09. Price change percentage: -0.01%
What Is the McKesson Market Cap?
As of today, McKesson market cap is 91.58B USD.
What Is McKesson's Earnings Per Share (TTM)?
The McKesson EPS (TTM) is 38.38.
When Is the Next McKesson Earnings Date?
McKesson will release its next earnings report on Aug 05, 2026.
From a Technical Analysis Perspective, Is MCK a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has McKesson Stock Split?
McKesson has split 2 times.
How Many Employees Does McKesson Have?
McKesson has 42300 employees.
What is the current trading status of McKesson (MCK)?
As of May 20, 2026, McKesson (MCK) is trading at a price of 761.89 USD, with a previous close of 775.97 USD. The stock has fluctuated within a day range of 761.89 USD to 782.48 USD, while its 52-week range spans from 637.00 USD to 999.00 USD.
What Is McKesson (MCK) Price Target According to Analysts?
The average 12-month price target for McKesson is 949.73 USD, with a high estimate of 1065 USD and a low estimate of 812 USD. 15 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +24.65% Upside potential.
What Is the MCK Premarket Price?
MCK's last pre-market stock price is 784.00 USD. The pre-market share volume is 520.00, and the stock has decreased by 8.03, or 1.03%.
What Is the MCK After Hours Price?
MCK's last after hours stock price is 761.80 USD, the stock has decreased by -0.09, or -0.01%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.